Browsing Over 392 Presentations
Sort By
Haematological malignancies
Educational session
Oncolytic virus therapy: A novel immunotherapeutic approach in haematologic malignancies (ID 380)
Lecture Time
11:25 - 11:50
Speakers
- Kah-Whye Peng (Rochester, NY, United States of America)
Session Name
Room
Room A
Date
Fri, Dec 9, 2022
Time
11:00 - 12:30
Mini Oral session 1
Mini Oral session
Invited Discussant (ID 414)
Lecture Time
10:00 - 10:10
Speakers
- Benjamin Besse (Villejuif, CE, France)
Session Name
Room
Room C
Date
Thu, Dec 8, 2022
Time
09:00 - 10:10
Next generation technologies for the optimal implementation of immunotherapy
Special session
Q&A (ID 37)
Lecture Time
17:15 - 17:30
Speakers
- Solange Peters (Lausanne, Switzerland)
Room
Room C
Date
Thu, Dec 8, 2022
Time
16:00 - 17:30
Novel clinical and translational insights in melanoma
Educational session
Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanoma (ID 86)
Lecture Time
09:00 - 09:20
Speakers
- Stephan Vagner (Villejuif, Cedex, France)
Room
Room A
Date
Thu, Dec 8, 2022
Time
09:00 - 10:30
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2
Industry satellite symposium
Emerging data for targeting IL-8, CXCR1, and/or CXCR2 as potential treatment options in solid tumors (ID 339)
Lecture Time
13:45 - 14:00
Speakers
- Matteo Simonelli (Milan, Italy)
Room
Room A
Date
Thu, Dec 8, 2022
Time
13:15 - 14:15
Cancer vaccines: Promise or dead end?
Controversy session
Introduction and first vote (ID 375)
Lecture Time
14:05 - 14:15
Speakers
- Stephen P. Schoenberger (La Jolla, CA, United States of America)
Session Name
Room
Room A
Date
Wed, Dec 7, 2022
Time
14:05 - 15:05
Vesalius talk: Overcoming the fear of leading: How to become a leader in your research group
Young Oncologists (YO) session
Panelist (ID 409)
Lecture Time
14:00 - 14:00
Speakers
- Nicolas Girard (Paris, France)
Session Name
Room
Room K
Date
Thu, Dec 8, 2022
Time
13:15 - 14:00
Welcome to the ESMO Immuno-Oncology Congress 2022 and Award
Opening session
Overcoming resistance to immunotherapy: Targeting innate immune cells (ID 28)
Lecture Time
13:25 - 13:50
Speakers
- Nina Bhardwaj (New York, NY, United States of America)
Room
Room B
Date
Wed, Dec 7, 2022
Time
13:15 - 13:50
Shared and neoantigen vaccines and T cells
Educational session
Lessons learned from dendritic cell vaccines (ID 368)
Lecture Time
09:25 - 09:50
Speakers
- Lisa H. Butterfield (San Francisco, CA, United States of America)
Session Name
Room
Room C
Date
Fri, Dec 9, 2022
Time
09:00 - 10:30
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2
Industry satellite symposium
Closing remarks and audience Q&A (ID 22)
Lecture Time
14:00 - 14:15
Speakers
- Vincenzo Bronte (Verona, Italy)
Room
Room A
Date
Thu, Dec 8, 2022
Time
13:15 - 14:15
Joint ESMO-SITC Immunotherapy Primer
Special session
Utilizing oncolytic virus as a new treatment modality (ID 76)
Lecture Time
10:10 - 10:30
Speakers
- Ramon Alemany (Hospitalet de Llobregat, Spain)
Session Name
Room
Room C
Date
Wed, Dec 7, 2022
Time
09:00 - 12:30
B cells as a therapeutic opportunity
Educational session
Regulatory B cells in cancer (ID 104)
Lecture Time
12:00 - 12:20
Speakers
- Claudia Mauri (London, United Kingdom)
Session Name
Room
Room B
Date
Thu, Dec 8, 2022
Time
11:00 - 12:30